A Study of Digital Cognitive Behavioural Therapy for Insomnia in Fibromyalgia
Key facts
- Who runs it
- University of Oxford
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 1 Jun 2023
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Digital Cognitive Behavioural Therapy for Insomnia
- Record updated
- 12 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Clinical diagnosis of fibromyalgia
- Concomitant insomnia, frequent waking in the night or early morning waking
- Self-reported difficulties with concentration or memory
- Reliable internet access
Who cannot take part
- Recent or planned surgery
- Taking prescribed sleep medications on more than 2 nights in past 2 weeks
- Currently receiving other psychological therapy for insomnia
- Patients with known neurological or psychiatric conditions (other than depression or anxiety) likely to independently affect the results of pain assessment, for example peripheral diabetic neuropathy in the opinion of the research team
- Major neuropsychiatric disorder (bipolar disorder, schizophrenia or psychotic spectrum disorders)
- Epilepsy
- Cognitive impairment, dementia or neurodegenerative disorder
- Sleep disorders such as sleep apnoea, restless leg syndrome, circadian rhythm disorder, or parasomnia
- Patients with a poor understanding of English
- Current or planned night-time shift work
- Pregnant or lactating
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to investigate the potential benefits of a digital Cognitive Behavioural Therapy for Insomnia (dCBT-I) platform, Sleepio, in individuals suffering from fibromyalgia, a condition commonly associated with cognitive issues and sleep disorders.
Read full original descriptionShow less
The main questions this study aims to answer are:
* Does the application of Sleepio improve quality of life in individuals with fibromyalgia? * Does the use of Sleepio improve cognitive function in individuals with fibromyalgia? * Does the use of Sleepio enhance sleep quality in these same individuals? * Does the use of Sleepio improve motor function in this group?
Participants will be randomly assigned to either use the Sleepio platform or standardised health advice, including sleep hygiene material. Those assigned to Sleepio will undergo a series of six 20-minute sessions over 10 weeks with a virtual therapist focusing on cognitive and behavioural strategies for improving sleep.
Participants' quality of life, cognitive function, sleep quality, and pain levels will be monitored and evaluated using online assessment tools. Additionally, a subset of participants will undergo further testing via sleep actigraphy and/or neuroimaging with MRI scans.
Researchers will compare the two groups to determine if the use of Sleepio has a positive effect on quality of life, cognitive function, and sleep quality.
The 2 groups in the trial
- Sleepio (dCBT-I)Treatment being tested
6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online. Participants will also receive a booklet with general advice for patients with fibromyalgia, including sleep hygiene.
Treatment: Digital Cognitive Behavioural Therapy for Insomnia
- Treatment as usualNo study treatment, for comparison
Participants will receive a booklet published by Versus Arthritis designed for patients with fibromyalgia with general advice, including sleep hygiene.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Characterisation of Pain in Patients With Musculoskeletal Disease: a Prospective, Longitudinal, Observational Study With an Embedded Feasibility Window of Opportunity Sleep Study
- Record updated
- 12 May 2026